Skip to content
Arbor Research
  • Home
  • About Us
    Our Team
    Our team
    Who We Are
    Who we are
    Our published research icon
    Our published research
    Careers
    Careers
    Board of directors
    Mission and vision
    Contact us
    Who We Serve
    • Our team
    • Board of directors
    • Who we are
    • Mission and vision
    • Our Published Research
    • Careers
    • Contact Us
  • Focus Areas
  • Capabilities
    • Real-World Evidence (RWE)
    • Program Evaluation, Implementation, and Applied Research
    • Mixed Method Research
    • Clinical Research
    • Data Coordinating Centers and Research Platforms
    • Health Policy Analysis
    • Digital Health Solutions
    • Clinical Quality Initiatives (CQI)
    • Disease and Treatment Registries
    • Technical Assistance
    • Clinical Trials Research Services
  • Markets
  • Impact

ArborWordPress

158 items

  • Serum proteomics uncovers biomarkers of portal hypertension in children with biliary atresia

    Large-scale proteomics identified SEMA6B, SFRP3, COMMD7, BMX, and VCAM1 as biomarkers highly associated with clinical portal hypertension in children with biliary atresia. The expression of the biomarkers in liver epithelial, endothelial, and immune cells support their potential role in the mechanisms that cause portal hypertension.

    Continue reading
  • Arbor Research Collaborative for Health Announces Partnership with Altarum to Support and Evaluate the National Hypertension Control Initiative

    Study partnership will address disparities in hypertension control among racial and ethnic minority populations

    Continue reading
  • Chauncy Lynch

    Arbor Research Collaborative for Health Announces Hire of Chauncey Lynch, BS, as Vice President of Finance & Chief Financial Officer

    Leader in broad-based finance and government contracting, Chauncey Lynch appointed to head Arbor Research finance team

    Continue reading
  • Shanthy Edward

    Arbor Research Collaborative for Health Announces Hire of Shanthy Edward, M.A., Psy.D. as Vice President of Strategic Growth & Chief Growth Officer

    Experienced business development professional Shanthy Edward, M.A., Psy.D. joins Arbor Research as Vice President of Strategic Growth & Chief Growth Officer.

    Continue reading
  • Arbor Research Collaborative for Health Announces New Board Members

    Leaders in public health and social justice, Deborah Klein Walker, EdD, Med, BA and Gerald M. Croan, SB, MCP join Arbor Research’s Board of Directors

    Continue reading
  • Portrait of Christopher Spera, PhD

    Arbor Research Collaborative for Health Appoints Chris Spera, PhD as New President & CEO

    Seasoned business leader and researcher, Chris Spera, Ph.D, takes the helm at Arbor Research, succeeding retiring president, Robert M. Merion, M.D. FACS.

    Continue reading
  • Launch of the US DOPPS Practice Monitor – Peritoneal Dialysis (DPM-PD), tracking the latest practice trends for patients receiving PD

    The Dialysis Outcomes and Practice Patterns (DOPPS) Program has expanded the DOPPS Practice Monitor (DPM) to include peritoneal dialysis (PD). The DPM-PD now reports the most up-to-date trends in care for patients receiving chronic PD in the US.

    Continue reading
  • Deleterious Variants in ABCC12 are Detected in Idiopathic Chronic Cholestasis and Cause Intrahepatic Bile Duct Loss in Model Organisms

    In a 1-year-old female patient with normal GGT cholestasis and bile duct paucity, we identified a homozygous truncating pathogenic variant (c.198delA, p.Gly67Alafs∗6) in the ABCC12 gene (NM_033226). Five additional rare ABCC12 variants, including a pathogenic one, were detected in our cohort.

    Continue reading
  • Arteriovenous Vascular Access–Related Procedural Burden Among Incident Hemodialysis Patients in the United States

    Using data from the United States Renal Data System (USRDS), our researchers calculated access procedure (intervention) rates in the US for patients starting hemodialysis with an AVF or AVG created during their first year of hemodialysis therapy between July 1, 2012 and December 31, 2014 (N = 73,027).

    Continue reading
  • Impaired Redox and Protein Hemeostasis as Risk Factors and Therapeutic Targets in Toxin-Induced Biliary Atresia

    Regional variation in glutathione metabolism underlies sensitivity to the biliary toxin biliatresone and may account for the reported association between BA transplant-free survival and glutathione metabolism gene expression.

    Continue reading
Previous141516Next
Arbor Research
  • Home
  • About Us
  • Focus Areas
  • Capabilities
  • Markets
  • Impact
  • Contact Us
  • News and press
  • Sitemap

Contact

Ann Arbor
3989 Research Park Dr.
Ann Arbor, MI 48108 USA

Washington D.C.
1640 Boro Place
McLean, VA 22102

communications@arborresearch.org
(734) 665-4108

© 2025 Arbor Research Collaborative for Health

Privacy statement    Terms of use

Arbor Research

Contact

Ann Arbor
3989 Research Park Dr.
Ann Arbor, MI 48108 USA

Washington D.C.
1640 Boro Place
McLean, VA 22102

communications@arborresearch.org
(734) 665-4108

© 2025 Arbor Research Collaborative for Health

Privacy statement    Terms of use

Page load link
Go to Top